Global Transdermal Drug Delivery Market 2024-2028
Global Transdermal Drug Delivery Market 2024-2028 The transdermal drug delivery market is forecasted to grow by USD 2.44 bn during 2023-2028, accelerating at a CAGR of 4.9% during the forecast per... もっと見る
日本語のページは自動翻訳を利用し作成しています。
SummaryGlobal Transdermal Drug Delivery Market 2024-2028The transdermal drug delivery market is forecasted to grow by USD 2.44 bn during 2023-2028, accelerating at a CAGR of 4.9% during the forecast period. The report on the transdermal drug delivery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic diseases, increased applications of transdermal patches, and biodegradable and biocompatible materials for transdermal drug delivery. Technavio's transdermal drug delivery market is segmented as below: By Application • Analgesics • Neurological disorders • Hormone replacement therapy • Cardiovascular disorders • Others By Type • Transdermal patches • Transdermal semisolids By Geography • North America • Europe • Asia • Rest of World (ROW) This study identifies the growing interest in transdermal medicines as one of the prime reasons driving the transdermal drug delivery market growth during the next few years. Also, robust demand for non-invasive treatment and growing focus on collaborations for business expansion will lead to sizable demand in the market. The report on the transdermal drug delivery market covers the following areas: • Transdermal drug delivery market sizing • Transdermal drug delivery market forecast • Transdermal drug delivery market industry analysis The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transdermal drug delivery market vendors that include 3M Co., Boehringer Ingelheim International GmbH, Croda International Plc, Hisamitsu Pharmaceutical Co. Inc., Johnson and Johnson, Kindeva Drug Delivery L.P., Luye Pharma Group Ltd., Medherant Ltd., Novartis AG, ProSolus Inc., Purdue Pharma LP, Radius Health Inc., Rusan Pharma Ltd., Sparsha Pharma International Pvt. Ltd., Teikoku Seiyaku Co. Ltd., UCB SA, and Viatris Inc.. Also, the transdermal drug delivery market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/transdermal-drug-delivery-industry-analysis The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth. Table of Contents• 1 Executive Summaryo 1.1 Market overview o Exhibit 01: Executive Summary - Chart on Market Overview o Exhibit 02: Executive Summary - Data Table on Market Overview o Exhibit 03: Executive Summary - Chart on Global Market Characteristics o Exhibit 04: Executive Summary - Chart on Market by Geography o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type o Exhibit 07: Executive Summary - Chart on Incremental Growth o Exhibit 08: Executive Summary - Data Table on Incremental Growth o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning • 2 Market Landscape o 2.1 Market ecosystem o Exhibit 10: Parent market o Exhibit 11: Market Characteristics • 3 Market Sizing o 3.1 Market definition o Exhibit 12: Offerings of vendors included in the market definition o 3.2 Market segment analysis o Exhibit 13: Market segments o 3.3 Market size 2023 o 3.4 Market outlook: Forecast for 2023-2028 o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion) o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion) o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%) o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%) • 4 Historic Market Size o 4.1 Global transdermal drug delivery market 2018 - 2022 o Exhibit 18: Historic Market Size - Data Table on global transdermal drug delivery market 2018 - 2022 ($ billion) o 4.2 Application Segment Analysis 2018 - 2022 o Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion) o 4.3 Type Segment Analysis 2018 - 2022 o Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion) o 4.4 Geography Segment Analysis 2018 - 2022 o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion) o 4.5 Country Segment Analysis 2018 - 2022 o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion) • 5 Five Forces Analysis o 5.1 Five forces summary o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028 o 5.2 Bargaining power of buyers o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028 o 5.3 Bargaining power of suppliers o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028 o 5.4 Threat of new entrants o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028 o 5.5 Threat of substitutes o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028 o 5.6 Threat of rivalry o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028 o 5.7 Market condition o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028 • 6 Market Segmentation by Application o 6.1 Market segments o Exhibit 30: Chart on Application - Market share 2023-2028 (%) o Exhibit 31: Data Table on Application - Market share 2023-2028 (%) o 6.2 Comparison by Application o Exhibit 32: Chart on Comparison by Application o Exhibit 33: Data Table on Comparison by Application o 6.3 Analgesics - Market size and forecast 2023-2028 o Exhibit 34: Chart on Analgesics - Market size and forecast 2023-2028 ($ billion) o Exhibit 35: Data Table on Analgesics - Market size and forecast 2023-2028 ($ billion) o Exhibit 36: Chart on Analgesics - Year-over-year growth 2023-2028 (%) o Exhibit 37: Data Table on Analgesics - Year-over-year growth 2023-2028 (%) o 6.4 Neurological disorders - Market size and forecast 2023-2028 o Exhibit 38: Chart on Neurological disorders - Market size and forecast 2023-2028 ($ billion) o Exhibit 39: Data Table on Neurological disorders - Market size and forecast 2023-2028 ($ billion) o Exhibit 40: Chart on Neurological disorders - Year-over-year growth 2023-2028 (%) o Exhibit 41: Data Table on Neurological disorders - Year-over-year growth 2023-2028 (%) o 6.5 Hormone replacement therapy - Market size and forecast 2023-2028 o Exhibit 42: Chart on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion) o Exhibit 43: Data Table on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion) o Exhibit 44: Chart on Hormone replacement therapy - Year-over-year growth 2023-2028 (%) o Exhibit 45: Data Table on Hormone replacement therapy - Year-over-year growth 2023-2028 (%) o 6.6 Cardiovascular disorders - Market size and forecast 2023-2028 o Exhibit 46: Chart on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion) o Exhibit 47: Data Table on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion) o Exhibit 48: Chart on Cardiovascular disorders - Year-over-year growth 2023-2028 (%) o Exhibit 49: Data Table on Cardiovascular disorders - Year-over-year growth 2023-2028 (%) o 6.7 Others - Market size and forecast 2023-2028 o Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion) o Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion) o Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%) o Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%) o 6.8 Market opportunity by Application o Exhibit 54: Market opportunity by Application ($ billion) o Exhibit 55: Data Table on Market opportunity by Application ($ billion) • 7 Market Segmentation by Type o 7.1 Market segments o Exhibit 56: Chart on Type - Market share 2023-2028 (%) o Exhibit 57: Data Table on Type - Market share 2023-2028 (%) o 7.2 Comparison by Type o Exhibit 58: Chart on Comparison by Type o Exhibit 59: Data Table on Comparison by Type o 7.3 Transdermal patches - Market size and forecast 2023-2028 o Exhibit 60: Chart on Transdermal patches - Market size and forecast 2023-2028 ($ billion) o Exhibit 61: Data Table on Transdermal patches - Market size and forecast 2023-2028 ($ billion) o Exhibit 62: Chart on Transdermal patches - Year-over-year growth 2023-2028 (%) o Exhibit 63: Data Table on Transdermal patches - Year-over-year growth 2023-2028 (%) o 7.4 Transdermal semisolids - Market size and forecast 2023-2028 o Exhibit 64: Chart on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion) o Exhibit 65: Data Table on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion) o Exhibit 66: Chart on Transdermal semisolids - Year-over-year growth 2023-2028 (%) o Exhibit 67: Data Table on Transdermal semisolids - Year-over-year growth 2023-2028 (%) o 7.5 Market opportunity by Type o Exhibit 68: Market opportunity by Type ($ billion) o Exhibit 69: Data Table on Market opportunity by Type ($ billion) • 8 Customer Landscape o 8.1 Customer landscape overview o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria • 9 Geographic Landscape o 9.1 Geographic segmentation o Exhibit 71: Chart on Market share by geography 2023-2028 (%) o Exhibit 72: Data Table on Market share by geography 2023-2028 (%) o 9.2 Geographic comparison o Exhibit 73: Chart on Geographic comparison o Exhibit 74: Data Table on Geographic comparison o 9.3 North America - Market size and forecast 2023-2028 o Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion) o Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion) o Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%) o Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%) o 9.4 Europe - Market size and forecast 2023-2028 o Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion) o Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion) o Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%) o Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%) o 9.5 Asia - Market size and forecast 2023-2028 o Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion) o Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion) o Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%) o Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%) o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028 o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) o 9.7 US - Market size and forecast 2023-2028 o Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion) o Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion) o Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%) o Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%) o 9.8 Germany - Market size and forecast 2023-2028 o Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion) o Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion) o Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%) o Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%) o 9.9 Japan - Market size and forecast 2023-2028 o Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion) o Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion) o Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%) o Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%) o 9.10 France - Market size and forecast 2023-2028 o Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ billion) o Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ billion) o Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%) o Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%) o 9.11 UK - Market size and forecast 2023-2028 o Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion) o Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion) o Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%) o Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%) o 9.12 Market opportunity by geography o Exhibit 111: Market opportunity by geography ($ billion) o Exhibit 112: Data Tables on Market opportunity by geography ($ billion) • 10 Drivers, Challenges, and Trends o 10.1 Market drivers o 10.2 Market challenges o 10.3 Impact of drivers and challenges o Exhibit 113: Impact of drivers and challenges in 2023 and 2028 o 10.4 Market trends • 11 Vendor Landscape o 11.1 Overview o 11.2 Vendor landscape o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation o 11.3 Landscape disruption o Exhibit 115: Overview on factors of disruption o 11.4 Industry risks o Exhibit 116: Impact of key risks on business • 12 Vendor Analysis o 12.1 Vendors covered o Exhibit 117: Vendors covered o 12.2 Market positioning of vendors o Exhibit 118: Matrix on vendor position and classification o 12.3 3M Co. o Exhibit 119: 3M Co. - Overview o Exhibit 120: 3M Co. - Business segments o Exhibit 121: 3M Co. - Key news o Exhibit 122: 3M Co. - Key offerings o Exhibit 123: 3M Co. - Segment focus o 12.4 Boehringer Ingelheim International GmbH o Exhibit 124: Boehringer Ingelheim International GmbH - Overview o Exhibit 125: Boehringer Ingelheim International GmbH - Business segments o Exhibit 126: Boehringer Ingelheim International GmbH - Key news o Exhibit 127: Boehringer Ingelheim International GmbH - Key offerings o Exhibit 128: Boehringer Ingelheim International GmbH - Segment focus o 12.5 Croda International Plc o Exhibit 129: Croda International Plc - Overview o Exhibit 130: Croda International Plc - Business segments o Exhibit 131: Croda International Plc - Key news o Exhibit 132: Croda International Plc - Key offerings o Exhibit 133: Croda International Plc - Segment focus o 12.6 Hisamitsu Pharmaceutical Co. Inc. o Exhibit 134: Hisamitsu Pharmaceutical Co. Inc. - Overview o Exhibit 135: Hisamitsu Pharmaceutical Co. Inc. - Product / Service o Exhibit 136: Hisamitsu Pharmaceutical Co. Inc. - Key offerings o 12.7 Johnson and Johnson o Exhibit 137: Johnson and Johnson - Overview o Exhibit 138: Johnson and Johnson - Business segments o Exhibit 139: Johnson and Johnson - Key news o Exhibit 140: Johnson and Johnson - Key offerings o Exhibit 141: Johnson and Johnson - Segment focus o 12.8 Kindeva Drug Delivery L.P. o Exhibit 142: Kindeva Drug Delivery L.P. - Overview o Exhibit 143: Kindeva Drug Delivery L.P. - Product / Service o Exhibit 144: Kindeva Drug Delivery L.P. - Key news o Exhibit 145: Kindeva Drug Delivery L.P. - Key offerings o 12.9 Luye Pharma Group Ltd. o Exhibit 146: Luye Pharma Group Ltd. - Overview o Exhibit 147: Luye Pharma Group Ltd. - Business segments o Exhibit 148: Luye Pharma Group Ltd. - Key offerings o Exhibit 149: Luye Pharma Group Ltd. - Segment focus o 12.10 Medherant Ltd. o Exhibit 150: Medherant Ltd. - Overview o Exhibit 151: Medherant Ltd. - Product / Service o Exhibit 152: Medherant Ltd. - Key offerings o 12.11 Novartis AG o Exhibit 153: Novartis AG - Overview o Exhibit 154: Novartis AG - Business segments o Exhibit 155: Novartis AG - Key offerings o Exhibit 156: Novartis AG - Segment focus o 12.12 ProSolus Inc. o Exhibit 157: ProSolus Inc. - Overview o Exhibit 158: ProSolus Inc. - Product / Service o Exhibit 159: ProSolus Inc. - Key offerings o 12.13 Purdue Pharma LP o Exhibit 160: Purdue Pharma LP - Overview o Exhibit 161: Purdue Pharma LP - Product / Service o Exhibit 162: Purdue Pharma LP - Key offerings o 12.14 Radius Health Inc. o Exhibit 163: Radius Health Inc. - Overview o Exhibit 164: Radius Health Inc. - Product / Service o Exhibit 165: Radius Health Inc. - Key offerings o 12.15 Teikoku Seiyaku Co. Ltd. o Exhibit 166: Teikoku Seiyaku Co. Ltd. - Overview o Exhibit 167: Teikoku Seiyaku Co. Ltd. - Product / Service o Exhibit 168: Teikoku Seiyaku Co. Ltd. - Key offerings o 12.16 UCB SA o Exhibit 169: UCB SA - Overview o Exhibit 170: UCB SA - Product / Service o Exhibit 171: UCB SA - Key offerings o 12.17 Viatris Inc. o Exhibit 172: Viatris Inc. - Overview o Exhibit 173: Viatris Inc. - Business segments o Exhibit 174: Viatris Inc. - Key news o Exhibit 175: Viatris Inc. - Key offerings o Exhibit 176: Viatris Inc. - Segment focus • 13 Appendix o 13.1 Scope of the report o 13.2 Inclusions and exclusions checklist o Exhibit 177: Inclusions checklist o Exhibit 178: Exclusions checklist o 13.3 Currency conversion rates for US$ o Exhibit 179: Currency conversion rates for US$ o 13.4 Research methodology o Exhibit 180: Research methodology o Exhibit 181: Validation techniques employed for market sizing o Exhibit 182: Information sources o 13.5 List of abbreviations o Exhibit 183: List of abbreviations Exhibits: Exhibits1: Executive Summary - Chart on Market Overview Exhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market by Geography Exhibits5: Executive Summary - Chart on Market Segmentation by Application Exhibits6: Executive Summary - Chart on Market Segmentation by Type Exhibits7: Executive Summary - Chart on Incremental Growth Exhibits8: Executive Summary - Data Table on Incremental Growth Exhibits9: Executive Summary - Chart on Vendor Market Positioning Exhibits10: Parent market Exhibits11: Market Characteristics Exhibits12: Offerings of vendors included in the market definition Exhibits13: Market segments Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion) Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion) Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%) Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%) Exhibits18: Historic Market Size - Data Table on global transdermal drug delivery market 2018 - 2022 ($ billion) Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ billion) Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion) Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion) Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion) Exhibits23: Five forces analysis - Comparison between 2023 and 2028 Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028 Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028 Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028 Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028 Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028 Exhibits29: Chart on Market condition - Five forces 2023 and 2028 Exhibits30: Chart on Application - Market share 2023-2028 (%) Exhibits31: Data Table on Application - Market share 2023-2028 (%) Exhibits32: Chart on Comparison by Application Exhibits33: Data Table on Comparison by Application Exhibits34: Chart on Analgesics - Market size and forecast 2023-2028 ($ billion) Exhibits35: Data Table on Analgesics - Market size and forecast 2023-2028 ($ billion) Exhibits36: Chart on Analgesics - Year-over-year growth 2023-2028 (%) Exhibits37: Data Table on Analgesics - Year-over-year growth 2023-2028 (%) Exhibits38: Chart on Neurological disorders - Market size and forecast 2023-2028 ($ billion) Exhibits39: Data Table on Neurological disorders - Market size and forecast 2023-2028 ($ billion) Exhibits40: Chart on Neurological disorders - Year-over-year growth 2023-2028 (%) Exhibits41: Data Table on Neurological disorders - Year-over-year growth 2023-2028 (%) Exhibits42: Chart on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion) Exhibits43: Data Table on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion) Exhibits44: Chart on Hormone replacement therapy - Year-over-year growth 2023-2028 (%) Exhibits45: Data Table on Hormone replacement therapy - Year-over-year growth 2023-2028 (%) Exhibits46: Chart on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion) Exhibits47: Data Table on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion) Exhibits48: Chart on Cardiovascular disorders - Year-over-year growth 2023-2028 (%) Exhibits49: Data Table on Cardiovascular disorders - Year-over-year growth 2023-2028 (%) Exhibits50: Chart on Others - Market size and forecast 2023-2028 ($ billion) Exhibits51: Data Table on Others - Market size and forecast 2023-2028 ($ billion) Exhibits52: Chart on Others - Year-over-year growth 2023-2028 (%) Exhibits53: Data Table on Others - Year-over-year growth 2023-2028 (%) Exhibits54: Market opportunity by Application ($ billion) Exhibits55: Data Table on Market opportunity by Application ($ billion) Exhibits56: Chart on Type - Market share 2023-2028 (%) Exhibits57: Data Table on Type - Market share 2023-2028 (%) Exhibits58: Chart on Comparison by Type Exhibits59: Data Table on Comparison by Type Exhibits60: Chart on Transdermal patches - Market size and forecast 2023-2028 ($ billion) Exhibits61: Data Table on Transdermal patches - Market size and forecast 2023-2028 ($ billion) Exhibits62: Chart on Transdermal patches - Year-over-year growth 2023-2028 (%) Exhibits63: Data Table on Transdermal patches - Year-over-year growth 2023-2028 (%) Exhibits64: Chart on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion) Exhibits65: Data Table on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion) Exhibits66: Chart on Transdermal semisolids - Year-over-year growth 2023-2028 (%) Exhibits67: Data Table on Transdermal semisolids - Year-over-year growth 2023-2028 (%) Exhibits68: Market opportunity by Type ($ billion) Exhibits69: Data Table on Market opportunity by Type ($ billion) Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits71: Chart on Market share by geography 2023-2028 (%) Exhibits72: Data Table on Market share by geography 2023-2028 (%) Exhibits73: Chart on Geographic comparison Exhibits74: Data Table on Geographic comparison Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ billion) Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ billion) Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%) Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%) Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ billion) Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion) Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%) Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%) Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ billion) Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion) Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%) Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%) Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ billion) Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ billion) Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%) Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%) Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ billion) Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion) Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%) Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%) Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ billion) Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion) Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%) Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%) Exhibits103: Chart on France - Market size and forecast 2023-2028 ($ billion) Exhibits104: Data Table on France - Market size and forecast 2023-2028 ($ billion) Exhibits105: Chart on France - Year-over-year growth 2023-2028 (%) Exhibits106: Data Table on France - Year-over-year growth 2023-2028 (%) Exhibits107: Chart on UK - Market size and forecast 2023-2028 ($ billion) Exhibits108: Data Table on UK - Market size and forecast 2023-2028 ($ billion) Exhibits109: Chart on UK - Year-over-year growth 2023-2028 (%) Exhibits110: Data Table on UK - Year-over-year growth 2023-2028 (%) Exhibits111: Market opportunity by geography ($ billion) Exhibits112: Data Tables on Market opportunity by geography ($ billion) Exhibits113: Impact of drivers and challenges in 2023 and 2028 Exhibits114: Overview on Criticality of inputs and Factors of differentiation Exhibits115: Overview on factors of disruption Exhibits116: Impact of key risks on business Exhibits117: Vendors covered Exhibits118: Matrix on vendor position and classification Exhibits119: 3M Co. - Overview Exhibits120: 3M Co. - Business segments Exhibits121: 3M Co. - Key news Exhibits122: 3M Co. - Key offerings Exhibits123: 3M Co. - Segment focus Exhibits124: Boehringer Ingelheim International GmbH - Overview Exhibits125: Boehringer Ingelheim International GmbH - Business segments Exhibits126: Boehringer Ingelheim International GmbH - Key news Exhibits127: Boehringer Ingelheim International GmbH - Key offerings Exhibits128: Boehringer Ingelheim International GmbH - Segment focus Exhibits129: Croda International Plc - Overview Exhibits130: Croda International Plc - Business segments Exhibits131: Croda International Plc - Key news Exhibits132: Croda International Plc - Key offerings Exhibits133: Croda International Plc - Segment focus Exhibits134: Hisamitsu Pharmaceutical Co. Inc. - Overview Exhibits135: Hisamitsu Pharmaceutical Co. Inc. - Product / Service Exhibits136: Hisamitsu Pharmaceutical Co. Inc. - Key offerings Exhibits137: Johnson and Johnson - Overview Exhibits138: Johnson and Johnson - Business segments Exhibits139: Johnson and Johnson - Key news Exhibits140: Johnson and Johnson - Key offerings Exhibits141: Johnson and Johnson - Segment focus Exhibits142: Kindeva Drug Delivery L.P. - Overview Exhibits143: Kindeva Drug Delivery L.P. - Product / Service Exhibits144: Kindeva Drug Delivery L.P. - Key news Exhibits145: Kindeva Drug Delivery L.P. - Key offerings Exhibits146: Luye Pharma Group Ltd. - Overview Exhibits147: Luye Pharma Group Ltd. - Business segments Exhibits148: Luye Pharma Group Ltd. - Key offerings Exhibits149: Luye Pharma Group Ltd. - Segment focus Exhibits150: Medherant Ltd. - Overview Exhibits151: Medherant Ltd. - Product / Service Exhibits152: Medherant Ltd. - Key offerings Exhibits153: Novartis AG - Overview Exhibits154: Novartis AG - Business segments Exhibits155: Novartis AG - Key offerings Exhibits156: Novartis AG - Segment focus Exhibits157: ProSolus Inc. - Overview Exhibits158: ProSolus Inc. - Product / Service Exhibits159: ProSolus Inc. - Key offerings Exhibits160: Purdue Pharma LP - Overview Exhibits161: Purdue Pharma LP - Product / Service Exhibits162: Purdue Pharma LP - Key offerings Exhibits163: Radius Health Inc. - Overview Exhibits164: Radius Health Inc. - Product / Service Exhibits165: Radius Health Inc. - Key offerings Exhibits166: Teikoku Seiyaku Co. Ltd. - Overview Exhibits167: Teikoku Seiyaku Co. Ltd. - Product / Service Exhibits168: Teikoku Seiyaku Co. Ltd. - Key offerings Exhibits169: UCB SA - Overview Exhibits170: UCB SA - Product / Service Exhibits171: UCB SA - Key offerings Exhibits172: Viatris Inc. - Overview Exhibits173: Viatris Inc. - Business segments Exhibits174: Viatris Inc. - Key news Exhibits175: Viatris Inc. - Key offerings Exhibits176: Viatris Inc. - Segment focus Exhibits177: Inclusions checklist Exhibits178: Exclusions checklist Exhibits179: Currency conversion rates for US$ Exhibits180: Research methodology Exhibits181: Validation techniques employed for market sizing Exhibits182: Information sources Exhibits183: List of abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
TechNavio社のHealth Care分野での最新刊レポート本レポートと同じKEY WORD(drug)の最新刊レポートよくあるご質問TechNavio社はどのような調査会社ですか?テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |